Sigma Healthcare Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Sigma Healthcare stock has a consensus rating of "Buy" and an average price target of $3.33. The average 1-year stock price forecast is 20.65% higher than the current stock price, while the lowest is $2.60 (-5.80%) and the highest is $3.90 (+41.30%).

Price Target: $3.33 (+20.65%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.60	$3.33	$3.40	$3.90
Change	-5.80%	+20.65%	+23.19%	+41.30%

Analyst Ratings

The average analyst rating for Sigma Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	4	4	6	8	8	8
Buy	4	4	3	2	3	3
Hold	3	4	4	3	3	3
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	12	13	14	14	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Macquarie No rating	Macquarie	Buy Maintains $3.50	Buy	Maintains	$3.50	+26.81%	Jun 9, 2026
Bryan Raymond J.P. Morgan	J.P. Morgan	Buy Maintains $3.50	Buy	Maintains	$3.50	+26.81%	May 7, 2026
Tom Godfrey Ord Minnett	Ord Minnett	Buy Maintains $3.30 → $3.40	Buy	Maintains	$3.30 → $3.40	+23.19%	May 6, 2026
Ben Gilbert Jarden	Jarden	Buy Maintains $3.60	Buy	Maintains	$3.60	+30.43%	May 5, 2026
Melinda Baxter Morgan Stanley	Morgan Stanley	Buy Maintains $3.20	Buy	Maintains	$3.20	+15.94%	May 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

10.87B

from 6.00B

81.18%

from 6.00B

Revenue Next Year

12.06B

from 10.87B

10.92%

from 10.87B

EPS This Year

0.06

from 0.06

17.03%

from 0.06

EPS Next Year

0.08

from 0.06

19.07%

from 0.06

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	2.42B	2.99B	3.09B	3.29B	6.00B	10.87B
Revenue Growth	-3.48%	23.67%	3.27%	6.59%	82.18%	81.18%
Gross Profit	668.30M	1.07B	917.70M	1.04B	1.44B	1.98B
Gross Margin	27.62%	35.83%	29.69%	31.66%	24.00%	18.25%
Operating Income	-69.53M	574.54M	428.73M	552.65M	769.21M	1.10B
Net Income	-175.98M	385.93M	304.33M	541.01M	529.91M	732.75M
EPS	-	-	-	-	0.06	0.06
EPS Growth	-	-	-	-	-	17.03%
Forward PE	-	-	-	-	-	42.86
Dividend / Share	-	-	-	-	0.01	0.04
Free Cash Flow	1.38B	140.63M	367.65M	48.92M	-187.60M	862.00M
No. Analysts	-	-	-	-	-	15

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue	2026	2027	2028
High	11.0B
Avg	10.9B
Low	10.6B

Revenue Growth

Revenue Growth	2026	2027	2028
High	84.0%
Avg	81.2%
Low	77.2%

EPS Forecast

EPS	2026	2027	2028
High	0.07
Avg	0.06
Low	0.06

EPS Growth

EPS Growth	2026	2027	2028
High	27.2%
Avg	17.0%
Low	9.0%